Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease-Reference-Cited by-同舟云学术

Entyvio lengthen dose-interval study: lengthening vedolizumab dose interval and the risk of clinical relapse in inflammatory bowel disease

Published:2018-07 Issue:7 Volume:30 Page:735-740
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Chan Webber,Lynch Nicole,Bampton Peter,Chang Jeff,Chung Alvin,Florin Timothy,Hetzel David J.,Jakobovits Simon,Moore Gregory,Pavli Paul,Radford-Smith Graham,Thin Lena,Baraty Brandon,Haifer Craig,Yau Yunki,Leong Rupert W.L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference16 articles.

1. Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin;Feagan;N Engl J Med,2005

2. α4 Integrins as therapeutic targets in autoimmune disease;Von Andrian;N Engl J Med,2003

3. Differential expression of mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in ulcerative colitis and Crohn’s disease;Arihiro;Pathol Int,2002

4. Vedolizumab as induction and maintenance therapy for ulcerative colitis;Feagan;N Engl J Med,2013

5. Vedolizumab as induction and maintenance therapy for Crohn’s disease;Sandborn;N Engl J Med,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case series;Therapeutic Advances in Gastroenterology;2024-01

2. De-escalation of Biologic Treatment in Inflammatory Bowel Disease: A Comprehensive Review;Journal of Crohn's and Colitis;2023-11-01

3. Exit strategies in inflammatory bowel disease: Looking beyond anti-tumor necrosis factors;World Journal of Clinical Cases;2023-04-26

4. Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis;ClinicoEconomics and Outcomes Research;2023-02

5. Magnetic resonance image healing correlating with long‐term clinical improvement in proximal small bowel Crohn disease treated with first‐line vedolizumab therapy;Internal Medicine Journal;2023-01